HbA~1c~ is proposed as the first of four diagnostic criteria for diabetes ([@B1]). Risk factors for diabetes as defined by self-reported diabetes, by treatment, by fasting plasma glucose (FPG), or by both fasting and 2-h glucose following an oral glucose tolerance test have been well studied, including in our own cohort ([@B2]--[@B6]). Risk factors for different definitions have not been compared; it is tacitly assumed they are the same.

We compare seven definitions of diabetes, using combinations of pharmacologic treatment, FPG ≥7.0 mmol/L, and HbA~1c~ ≥6.5% to evaluate the incidences of diabetes and compare baseline risk factors for men and women separately. Furthermore, we evaluate the odds ratios of risk factors and the ability of the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) clinical risk factor score ([@B2]) to discriminate those with and without incident diabetes.

RESEARCH DESIGN AND METHODS {#s5}
===========================

Men and women aged 30--65 years, from the 9-year follow-up study DESIR ([@B2]), were included. Incidences of diabetes by FPG and HbA~1c~ definitions were compared with the McNemar test.

Odds ratios for potential risk factors are given for incident diabetes according to the seven definitions of diabetes ([Table 1](#T1){ref-type="table"}). Sex-risk factor interactions were tested, and in consequence, sex-specific odds ratios are given for smoking and familial diabetes.

###### 

Odds ratios (95% CI), univariable analysis, for incident diabetes according to seven definitions of diabetes: the DESIR study

                                                           Treatment                     FPG ≥7.0 mmol/L              HbA~1c~ ≥6.5%                FPG ≥7.0 mmo/L and/or HbA~1c~ ≥6.5%   FPG ≥7.0 mmol/L and/or treatment   HbA~1c~ ≥6.5% and/or treatment   FPG ≥7.0 mmol/L and/or HbA~1c~ ≥6.5% and/or treatment
  -------------------------------------------------------- ----------------------------- ---------------------------- ---------------------------- ------------------------------------- ---------------------------------- -------------------------------- -------------------------------------------------------
  Women                                                    0.51 (0.34--0.77) 0.0010      0.38 (0.26--0.53) \<0.0001   0.66 (0.46--0.95) 0.0242     0.48 (0.36--0.63) \<0.0001            0.41 (0.30--0.56) \<0.0001         0.62 (0.45--0.86) 0.0038         0.50 (0.38--0.65) \<0.0001
  Age (1 year)                                             1.08 (1.05--1.10) \<0.0001    1.03 (1.01--1.05) \<0.0001   1.07 (1.05--1.10) \<0.0001   1.05 (1.04--1.07) \<0.0001            1.04 (1.02--1.06) \<0.0001         1.07 (1.05--1.10) \<0.0001       1.06 (1.04--1.07) \<0.0001
  Diabetes in family                                                                                                                                                                                                                                         
   Men                                                     1.55 (0.89--2.68) 0.1197      1.02 (0.63--1.65) 0.9330     1.35 (0.77--2.36) 0.2875     1.19 (0.78--1.80) 0.4168              1.12 (0.73--1.74) 0.5929           1.54 (0.96--2.46) 0.0712         1.30 (0.89--1.91) 0.1745
   Women                                                   3.30 (1.72--6.32) 0.0003      3.38 (1.90--6.01) \<0.0001   1.49 (0.80--2.79) 0.2087     2.06 (1.27--3.34) 0.0036              3.11 (1.86--5.20) \<0.0001         1.76 (1.02--3.01) 0.0395         2.06 (1.31--3.21) 0.0016
  Current smoker                                                                                                                                                                                                                                             
   Men                                                     2.27 (1.39--3.70) 0.0009      1.89 (1.28--2.79) 0.0012     1.46 (0.89--2.42) 0.1331     1.70 (1.20--2.42) 0.0031              1.83 (1.28--2.64) 0.0009           1.59 (1.03--2.44) 0.0344         1.68 (1.21--2.35) 0.0022
   Women                                                   0.36 (0.08--1.53) 0.1674      1.49 (0.71--3.11) 0.2899     1.20 (0.55--2.58) 0.6452     1.45 (0.80--2.62) 0.2211              1.25 (0.62--2.49) 0.5292           1.04 (0.50--2.13) 0.9175         1.27 (0.72--2.25) 0.4041
  Alcohol (g/day)                                                                                                                                                                                                                                            
   0                                                       1                             1                            1                            1                                     1                                  1                                1
   0--19                                                   1.01 (0.56--1.80)             1.48 (0.89--2.43)            0.75 (0.44--1.26)            1.04 (0.69--1.57)                     1.32 (0.84--2.06)                  0.82 (0.52--1.31)                0.95 (0.65--1.39)
   20--39                                                  1.28 (0.74--2.19)             1.73 (1.08--2.78)            0.86 (0.53--1.39)            1.38 (0.95--2.00)                     1.63 (1.07--2.47)                  1.00 (0.65--1.52)                1.31 (0.93--1.84)
   ≥40                                                     3.16 (1.70--5.87)             4.75 (2.79--8.08)            2.69 (1.57--4.61)            3.38 (2.17--5.28)                     4.01 (2.47--6.51)                  2.62 (1.60--4.30)                3.00 (1.98--4.55)
                                                           0.0004                        \<0.0001                     \<0.0001                     \<0.0001                              \<0.0001                           \<0.0001                         \<0.0001
  Sedentary                                                1.65 (1.10--2.47) 0.0144      1.30 (0.92--1.83) 0.1265     2.12 (1.47--3.05) \<0.0001   1.56 (1.17--2.07) 0.0024              1.45 (1.06--1.97) 0.0171           2.07 (1.50--2.86) \<0.0001       1.67 (1.28--2.17) 0.0002
  Waist (1 cm)                                             1.13 (1.10--1.16) \<0.0001    1.09 (1.07--1.11) \<0.0001   1.09 (1.07--1.12) \<0.0001   1.09 (1.08--1.11) \<0.0001            1.10 (1.08--1.12) \<0.0001         1.10 (1.08--1.12) \<0.0001       1.10 (1.08--1.11) \<0.0001
  BMI (1 kg/m^2^)                                          1.32 (1.26--1.38) \<0.0001    1.23 (1.18--1.28) \<0.0001   1.25 (1.20--1.31) \<0.0001   1.23 (1.19--1.27) \<0.0001            1.25 (1.20--1.30) \<0.0001         1.28 (1.22--1.33) \<0.0001       1.25 (1.21--1.29) \<0.0001
  Hypertension                                             6.80 (4.29--10.76) \<0.0001   2.94 (2.14--4.03) \<0.0001   3.48 (2.40--5.03) \<0.0001   2.99 (2.28--3.94) \<0.0001            3.27 (2.44--4.38) \<0.0001         4.48 (3.19--6.28) \<0.0001       3.37 (2.60--4.37) \<0.0001
  Lipid treatment                                          3.14 (1.91--5.14) \<0.0001    1.98 (1.24--3.16) 0.0040     3.18 (2.00--5.06) \<0.0001   2.19 (1.47--3.25) 0.0001              2.19 (1.45--3.31) 0.0002           3.01 (1.98--4.57) \<0.0001       2.2 (1.56--3.25) \<0.0001
  AROC curve (95% CIs) for the DESIR diabetes risk score                                                                                                                                                                                                     
   DESIR score[\*](#t1n1){ref-type="table-fn"}             0.86 (0.83--0.89)             0.74 (0.70--0.78)            0.77 (0.72--0.82)            0.75 (0.71--0.78)                     0.76 (0.72--0.80)                  0.80 (0.76--0.83)                0.76 (0.73--0.80)

Data are expressed as OR (95% CI) *P. N*, case patients with incident diabetes: treatment, 108/3,872; FPG ≥7.0 mmol/L, 168/3,790; HbA~1c~ ≥6.5%, 126/3,789; FPG ≥7.0 mmol/L and/or HbA~1c~ ≥6.5%, 228/3,800; FPG ≥7.0 mmol/L and/or treatment, 203/3,825; HbA~1c~ ≥6.5% and/or treatment, 165/3,828; and FPG ≥7.0 mmol/L and/or HbA~1c~ ≥6.5% and/or treatment, 264/3,836.

\*Reference 2.

The DESIR diabetes risk score ([@B2]) includes waist circumference, hypertension, and for men, current smoking, or for women, familial diabetes; the score was derived with diabetes defined by treatment and/or FPG ≥7.0 mmol/L ([Supplementary Table 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc10-1581/-/DC1)). The discrimination of this score was evaluated, for each of the seven definitions, by the area under the receiver operating characteristic curve (AROC).

RESULTS {#s6}
=======

At inclusion, men and women were on average aged 47 years, and 19% had familial diabetes, 25% were sedentary, and mean BMI was 24.6 kg/m^2^ ([Supplementary Table 2](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc10-1581/-/DC1)). Mean FPG was higher in men than women, with a constant difference of 0.35 mmol/L over the age range (*P*~interaction~= 0.6) ([Supplementary Fig. 1](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc10-1581/-/DC1)). Mean HbA~1c~ was also higher in men, but this difference decreased with age (*P*~interaction~= 0.0001): mean HbA~1c~ was 0.25% higher in men 30--34 years and identical in men and women 60--65 years.

For diabetes defined by FPG and/or treatment, in comparison with HbA~1c~ and/or treatment, incidences were higher in men: 7.5% (95% CI 6.3--8.9) and 5.3% (4.2--6.5) (*P* \< 0.0003); in women the incidences were similar: 3.2% (2.4--4.2) and 3.4% (2.6--4.3) ([Supplementary Table 3](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc10-1581/-/DC1)).

Characteristics of case patients with incident diabetes varied according to the definition of diabetes ([Supplementary Tables 2 and 3](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc10-1581/-/DC1)). For diabetes defined by treatment alone, risk factors were age, waist circumference, BMI, hypertension, and lipid treatment (all *P* \< 0.006). For men only, additional factors were smoking, alcohol intake, and sedentarity (all *P* \< 0.05), and for women only, an additional factor was familial diabetes (*P* \< 0.0001). When comparing case patients with incident diabetes screened only by FPG and case patients screened only by HbA~1c~, more were men (78 vs. 35%), case patients were 8 years younger (after sex adjustment), and fewer were alcohol abstainers (12 vs. 36% after adjusting for age and sex) (all *P* \< 0.01) ([Supplementary Table 4](http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc10-1581/-/DC1)).

Although the classical risk factors sex, age, alcohol intake, waist, BMI, hypertension, and lipid treatment were associated with incident diabetes, no matter what the definition ([Table 1](#T1){ref-type="table"}), the univariable odds ratios for the various definitions differed. The most marked difference was for hypertension, where the odds ratios ranged from a low of 2.94 (2.14--4.03) when diabetes was defined by FPG alone to 6.80 (4.29--10.76) when defined by treatment alone.

The DESIR diabetes risk score ([@B2]) performed well for all definitions of diabetes, particularly so when diabetes was defined by treatment alone, with an AROC (95% CI) of 0.86 (0.83--0.89), in comparison with 0.76 (0.72--0.80) when diabetes was defined by FPG and/or treatment, the definition on which the score was derived.

CONCLUSIONS {#s7}
===========

The age profile of HbA~1c~ and FPG differed for men and women, with FPG always higher in men, whereas HbA~1c~ was higher in younger men but identical in the oldest age range, 60--65 years. For men only, the incidence of diabetes was lower for diabetes defined by HbA~1c~ rather than by FPG. There has been little discussion in the literature on the differences between men and women for either FPG or HbA~1c~.

For the incident diabetic case patients diagnosed by treatment, the classic risk factors for diabetes were mainly higher than for other definitions---age, diabetes in the family, adiposity, hypertension, with smoking and alcohol drinking in men. This is probably because of the general practitioner recognizing these as risk factors and screening for diabetes, subsequently diagnosing and treating the patient. Hypertension and lipid treatment were risk factors with high odds ratios in those who had incident diabetes by treatment, probably for the same reason.

For the definitions of diabetes with FPG there were more men, case patients were younger, and fewer were alcohol abstainers than for definitions with HbA~1c~. Despite this, the diabetes risk score discriminated well for all definitions of diabetes, best for diabetes defined by treatment and worst for diabetes defined by FPG alone, but all AROCs were over 0.74.

In Inter99, the cross-sectional profiles were similar for those screened diabetic only by HbA~1c~ and only by FPG and 2-h plasma glucose ([@B7]); however, diabetes prevalence was higher when screened by HbA~1c~, in contrast with our incidence study. Mean HbA~1c~ in Inter99 appears higher than in other cohorts, and this is probably the reason for the observed difference ([@B8]). Differences in men and women were not studied in Inter99.

Because blood was only sampled at one time point to evaluate FPG and HbA~1c~, this study is limited to diabetes screening---not diagnosis. Furthermore, although our HbA~1c~ assay conformed to the Diabetes Control and Complications Trial (DCCT)/National Glycohemoglobin Standardization Program (NGSP) standards, it was not linked to the International Federation of Clinical Chemistry reference method ([@B1]).

In summary, the main differences between those who become diabetic according to the FPG and HbA~1c~ definitions of diabetes were the higher frequency of men and the younger mean age by the FPG definitions. FPG screened more incident diabetes in men than HbA~1c~; for women, the percentages were similar.

Supplementary Material
======================

###### Supplementary Data

This article contains Supplementary Data online at <http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc10-1581/-/DC1>.

A complete list of the members of the DESIR Study Group can be found in the [APPENDIX]{.smallcaps}.
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